Determination of drug reference substance content by 1H-nuclear magnetic resonance spectroscopy

Fenxi Huaxue

Volumn 32, Issue 4, 2004, Pages 451-455

  Hu, Min ^a   Hu, Changqin ^b   Liu, Wenying ^c  

^a Hubei Institute for Drug Control   (China)

^b NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Nuclear magnetic resonance; Quantitative analysis; Quinolone

Indexed keywords

ANTOFLOXACIN; CADEROFLOXACIN; CIPROFLOXACIN; DEUTERIUM OXIDE; DIMETHYL SULFOXIDE; ENOXACIN; GATIFLOXACIN; HYDROQUINONE; LOMEFLOXACIN; MALEIC ACID; NORFLOXACIN; OFLOXACIN; QUINOLONE DERIVATIVE; SODIUM HYDROXIDE; SOLVENT; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; DRUG DETERMINATION; FEASIBILITY STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS;

EID: 2342607960     PISSN: 02533820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Zhu Jihong, Yang Lahu. Chinese J. Pharm. Anal., 1987, 7(4):252-254
2. Van Dooren A A, Muller B W. Inter. J. Pharm., 1984, 20:217-233
3. Yang Lahu. Chinese J. Pharm. Anal., 1988, 8(6):345-346
4. Rackham D M. Talanta, 1976, 23:269-274
5. USP 24/NF19: 1221-1222
6. Liu Ying, Hu Changqin. Chinese J. Pharm. Anal., 2001, 21(6):447-452
7. USP24/NF19: 1959-1965